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Kamala is a Pitta Pradhana[1] and Rakta  Pradoshaja  
Vikara.[2] Two types of Kamala are mentioned in 
Ayurvedic classics viz -  Kostashakhashrita Kamala and 
Shakhashrita  Kamala.[3] Kostashakasrita Kamala is 
characterized by Peeta Netra, Mootra, Twak, Nakha, 
Varchas Bekha Varna and Hatha Indrya.[4] 
Kostashakhashrita   Kamala    can    be   correlated   to   
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Hepato cellular jaundice of western system of 
medicine. Among different varieties of Hepato cellular 
jaundice Viral Hepatitis is the most common one. The 
term Viral Hepatitis refers to infection of the liver 
caused by five well characterised hepatotropic 
viruses, they are hepatitis A, B, C, D & E.[5]  
Prevalence of Viral Hepatitis is 1.08% to 2.72% 
globally, the frequency being similar in males and 
females.[6] The  treatment  modalities  described  in  
Ayurveda  for  Kostashakhashrita Kamala  include  
both  Shodhana  and  Shamana. Among  different  
varieties  of Shamanoushadhis the formulations  
which possess Pitta Rechana, Raktashodhana, Yakrit 
Uttejaka,  Daha  Prashanmana,  Jwaraghna,  
Rasayana  and  Balya  properties  herbs  are 
specifically required. 
MATERIALS AND METHODS 
Source of data 
Subjects of Kostashakhashrita Kamala vis-à-vis Viral 
Hepatitis were selected from the OPD and IPD of  
A B S T R A C T  
Kamala is a one among the Rakta Pradoshaja Vikara, where there is aversion towards all desires.  Two 
types of Kamala are mentioned in Ayurvedic classics viz Kostashakhashrita Kamala and Shakhashrita 
Kamala. Kostashakhashrita Kamala in its definition includes the condition which is mentioned as viral 
hepatitis in western system of medicine.  The  treatment  modalities described  in  Ayurveda  for  
Kostashakhashrita Kamala  include  both  Shodhana  and  Shamana. This study is an attempt to 
evaluate  the efficacy  of  Nimba,  Amrita,  Bhumyamalaki, Bhringaraja  and  Katuki  (NABBK) 
Kashaya  and  compare  its  efficacy  with  that  of   Nimba,  Amrita,  Bhumyamalaki, Bhringaraja 
(NABB)  Swarasa with  Katuki Churna in Kostashakhashrita  Kamala vis-à-vis Viral Hepatitis.  Overall 
difference between two groups showed statistically non-significant result with ‘p’ value 0.953. 
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Government  Ayurveda  Medical College  &  Hospital, 
Mysuru. 
Diagnostic criteria  
Diagnosis of the cases was made in the present study 
according to the changes in the  biochemical  values  
of   liver  function test (LFT),  signs   and   symptoms  
of Kostashakhashrita Kamala were as follows; 
Changes in the biochemical values of LFT 
▪ Increased  Total  bilirubin  with  direct  Bilirubin  
relatively  more  than  Indirect bilirubin.  
▪ Increased SGOT and SGPT level with SGPT 
relatively more than SGOT.  
▪ Increased Alkaline phosphatase exceeding twice 
the upper limit of normal. 
Signs and symptoms of Kostashakhashrita Kamala 
vis-à-vis Viral Hepatitis 
1. Peeta Netra (Icterus) 
2. Peeta Twak (Yellowish discolouration of skin) 
3. Peeta Varchas (Yellowish discolouration of stool) 
4. Peeta Mutra (Yellowish discolouration of urine) 
Inclusion criteria 
▪ Subjects with signs & symptoms of 
Kostashakhashrita Kamala vis-à-vis Viral Hepatitis 
such as Peeta Netra, Mutra Twak,  Peeta Varchas, 
Dourbalya,  Aruchi and impaired values of LFT 
were included in the study. Subjects of all gender 
were included in the study. 
▪ Subjects between the age Group of 16-70 years 
were selected in the study. 
▪ Both fresh and treated cases were included in the 
study. 
Exclusion criteria  
▪ Pregnant and lactating women were excluded 
from the study. 
▪ Subjects  of  Liver  cirrhosis,  Obstructive  
jaundice,  Hemolytic  jaundice, Alcoholic  liver  
disease  and  Drug  induced  hepatitis  were  
excluded  from  the study. 
▪ Hepatitis  associated  with  other  Systemic  
disease  such  as  –Uncontrolled Diabetes Mellitus, 
Hepatorenal Syndome, Hepatic Encephalopathy, 
Fulminant  Hepatitis (Massive hepatic necrosis), 
Respiratory Failure  and Cardiovascular  Failure 
were excluded from the study. 
Intervention 
The interventions were as follows: 
In Group A  –  The Swarasa of Nimba, Amrita, 
Bhumyamalaki, Bhringaraja  (NABB) each  in  equal  
quantity  consisting  48ml  as  the  total  dosage  in  
two  equally  divided dosage  once  in  the  morning  
and  once  the  evening,  before  food  with  Madhu  
was administered as Anupana for 15 consecutive 
days. 
Katuki  Churna  in  the  dose  of  6gms  in  a  two  
equally  divided  dosage  was  administered along with 
Swarasa. 
In  Group  B  –  The  Kashaya  of  Nimba,  Amrita,  
Bhumyamalaki,  Bhringaraja  and Katuki  (NABBK)  
each  one  part  consisting  96ml  as  the  total  dosage  
in  two  equally divided dosage once in the morning 
and once in the evening, before food with Ushna jala 
was administered as Anupana for 15 consecutive 
days. 
Assessment Criteria  
Assessment parameters included the clinical grading 
of signs and symptoms of the disease 
Kostashakhashrita Kamala / Viral Hepatitis. 
Assessment was done based on following parameters. 
Biochemical Parameters 
Liver Function Test 
Total Bilirubin, Direct bilirubin, SGOT, SGPT, Alkaline 
phosphatase.  
Clinical Parameters 
Peeta Netra (Icterus), Peeta Twak (Yellowish 
discolouration of skin), Peeta Varchas (Yellowish 
discolouration of stool), Peeta Mutra (Yellowish 
discolouration of urine), Dourbalya (Fatigue), Aruchi 
Dr. Shivappa A. Gangal et al. A comparative clinical study in the management of Kostashakhashrita Kamala 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE Nov-Dec 2020 
 
Journal of Ayurveda and Integrated Medical Sciences | Nov - Dec  2020 | Vol. 5 | Issue 6 12 
 
(Anorexia), Chardi (Nausea & Vomiting), Jwara 
(Fever). 
Rating and Scoring for Assessment (signs & 
symptoms) 
Peeta Netra (PN) 
PN0 – Absent 
PN1 – Mild   
PN2 – Moderate 
PT3 – Severe   
Peeta Twak (PT)    
PT0 – Absent                             
PT1 – Mild                                
PT2 – Moderate                              
PT3 – Severe  
Peeta Varchas (PV)    
PV0 – Absent                                
PV1 – Mild                                  
PV2 – Moderate                                  
PV3 – Severe  
Peeta Mutra (PM)    
PM0 - Absent                                
PM1 - Mild                                
PM2 - Moderate                                
PM3 – Severe  
Dourbalya (D)        
D0 – Absent                               
D1 – Mild                                
D2 – Moderate                                
D3 – Severe  
Aruchi  (A)              
A0- Absent                                
A1– Present  
Chardi (C)               
C0 – Absent                                
C1 – Present    
Jwara (J)     
J0 – Absent                    
J1 – Present  
Assessment Schedule  
In this clinical trial, total three assessments of the 
subjects were made. 
1. Pre test assessment was done on the day of 
intervention i.e., 0 day – Assessment was done 
with respect to Signs and Symptoms and LFT. 
2. Mid test assessment was done on 8th day of 
intervention - Assessment was done with respect 
to Signs and Symptoms. 
3. Post test assessment was done on 15th day of 
intervention - Assessment was done with respect 
to Signs and Symptoms and LFT  
Overall Assessment  
The assessment was Graded (G) with following 
manner: 
▪ G1 - Marked improvement:  Reduction in all the 
signs and symptoms except any one sign or 
symptom in subjects. Marked changes in the LFT 
value. 
▪ G2 - Moderate improvement:  Reduction in all the 
signs and symptoms except any  two signs or 
symptoms in subjects. Moderate changes in the 
LFT value. 
▪ G3 - Mild improvement:  Reduction in any two 
sign or symptom in subjects. Mild changes in the 
LFT value. 
▪ G4 - Insignificant improvement:  No Reduction in 
any signs and symptoms in subjects. No changes 
in the LFT value. 
Statistical Methods  
The data was collected before intervention i.e., on 0 
day,   during   the intervention i.e., on 8th day and 
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after the completion of intervention period i.e., on 
15th day. The result was analyzed statistically by using 
Descriptive statistics, Repeated measures ANOVA and 
Contingency co-efficient test analysis using Service 
product for statistical solution (SPSS) for windows 
software. 
OBSERVATION AND RESULTS 
General observations 
In  the present study among 46 subjects who 
completed the clinical trial maximum number of 
subjects belonged to the age group of 21 – 30 (41.3%) 
years,  Majority were driver and labour 9(19.6 % 
each). Majority of subjects belonged to male gender 
40 (87.0%), belonged to Hindu religion 40 (87.0%), 
belonged to Higher Secondary education 14 (26.1%). 
28 (60.9%) subjects were married. Majority of 
subjects belonged to upper middle class family 18 
(39.1%), 35 (76.1%)  subjects approached the hospital 
for the first time to take  treatment  and  11  (23.9%)  
had  already  taken  different  forms  of  treatment  of 
varying duration. Majority of subjects belonged to 
mixed food habits 37 (80.4%), 24 (52.2%) were of 
Pitta Kapha Prakruti and 24 (52.2%) belonged to 
urban locality.  
Results  
In the present comparative clinical study both the 
groups showed  statistically highly  significant  result  
in  the  following  components  i.e.,  Peeta  Netra  with  
p  value 0.000, Peeta Mutra with p value 0.000, 
Dourbalya with p value 0.000, Aruchi with p value  
0.000,  Chardi  with  p  value  0.000  and  Jwara  with  
p-value  0.000.  Peeta Twak showed  non-significant  
result  in  both  the  groups,  Peeta  Varchas  showed  
highly significant result in group A with p value 0.000 
and non-significant result in group B with p value 
0.172. And both the groups showed highly significant 
result in reduction of total bilirubin with p value 
0.000, direct bilirubin with p value 0.000, SGPT with p 
value 0.000 and alkaline phosphatase with p value 
0.000, reduction in SGOT with p value 0.000 in Group 
A, p value 0.002 in Group B. The result of Overall 
difference in between two groups showed statistically 
non - significant result with  p value 0.953. 























































































































C.C 0.544 0.000 
N of Valid Cases 69  
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Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.720 0.000 





C.C 0.847 0.000 
N of Valid Cases 69  
Table 3: Showing result on Peeta Twak. 
Group
s  















































63(91.3%) 5(7.2%) 1(1.4%) 
69(100.0
%) 
Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.239 0.097 





C.C 0.134 0.645 
N of Valid Cases 69  
Table 4: Showing result on Peeta Varchas. 
Group
s  











































59(85.5%) 8(11.6%) 2(2.9%) 69(100.0
%) 
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Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.402 0.000 





C.C 0.215 0.172 
N of Valid Cases 69  




























































































Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.756 0.000 





C.C 0.798 0.000 
N of Valid Cases 69  
Table 6: Showing result on Aruchi.   
Groups  Day  Absent  Present  Total  
Group A 0 day 1(4.3%) 22(95.7%) 23(100.0%) 
8th day  22(95.7%) 1(4.3%) 23(100.0%) 
15th day 23(100.0%) 0(0.0%) 23(100.0%) 
Total  46(66.7%) 23(33.3%) 69(100.0%) 
Group B 0 day 3(13.0%) 20(87.0%) 23(100.0%) 
8th day  23(100.0%) 0(0.0%) 23(100.0%) 
15th day 23(100.0%) 0(0.0%) 23(100.0%) 
Total  49(71.0%) 20(29.0%) 69(100.0%) 
Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.936 0.000 





C.C 0.904 0.000 
N of Valid Cases 69  
Table 7: Showing result on Chardi. 
Groups  Day  Absent  Present  Total  
Group A 0 day 11(47.8%) 12(52.2%) 23(100.0%) 
8th day  23(100.0%) 0(0.0%) 23(100.0%) 
15th day 23(100.0%) 0(0.0%) 23(100.0%) 
Total  57(82.6%) 12(17.4%) 69(100.0%) 
Group B 0 day 8(34.8%) 15(65.2%) 23(100.0%) 
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8th day  23(100.0%) 0(0.0%) 23(100.0%) 
15th day 23(100.0%) 0(0.0%) 23(100.0%) 
Total  54(78.3%) 15(21.7%) 69(100.0%) 
Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.649 0.000 





C.C 0.745 0.000 
N of Valid Cases 69  
Table 8: Showing result on Jwara. 
Groups  Day  Absent  Present  Total  
Group A 0 day 12(52.2%) 11(47.8%) 23(100.0%) 
8th day  23(100.0%) 0(0.0%) 23(100.0%) 
15th day 23(100.0%) 0(0.0%) 23(100.0%) 
Total  58(84.1%) 11(15.9%) 69(100.0%) 
Group B 0 day 12(52.2%) 11(47.8%) 23(100.0%) 
8th day  23(100.0%) 0(0.0%) 23(100.0%) 
15th day 23(100.0%) 0(0.0%) 23(100.0%) 
Total  58(84.1%) 11(15.9%) 69(100.0%) 
Tests of Within-Subjects Effects 
Symmetric Measures 





C.C 0.616 0.000 





C.C 0.616 0.000 
N of Valid Cases 69  
Biochemical Parameters  
Table 9: Showing result on Total Bilirubin. 
Descriptive Statistics 





Group  A 10.8722 4.59118 23 
Group B 9.7696 5.97681 23 
Total 10.3209 5.29907 46 
Post 
Test 
Group A 3.0783 1.17394 23 
Group B 3.3696 4.72724 23 
Total 3.2239 3.40889 46 
Tests of Within-Subjects Effects 






Change 1158.436 1 1158.436 146.779 .000 
change * Group 11.172 1 11.172 1.416 .241 
Table 9: Showing result on Direct Bilirubin. 
Descriptive Statistics 
 Group Mean Std. 
Deviation 
N 
Pre test  Group A 5.4000 2.70421 23 
Group B 4.7391 2.87714 23 
Total 5.0696 2.78096 46 
Post test  Group A 1.5739 .76587 23 
Group B 1.5130 1.56185 23 
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Total 1.5435 1.21667 46 
Tests of Within-Subjects Effects 






Change 285.966 1 285.966 125.568 .000 
change * Group 2.070 1 2.070 .909 .346 
Table 10: Showing result on SGOT 
Descriptive Statistics 
 Groups Mean Std. Deviation N 
Pre test Group 
A 
206.2391 162.32920 23 
Group 
B 
309.2391 359.55641 23 
Total 257.7391 280.70935 46 
Post test Group 
A 
55.3609 19.36986 23 
Group 
B 
54.6783 31.84105 23 
Total 55.0196 26.06161 46 
Tests of Within-Subjects Effects 






Change 945190.109 1 945190.109 27.060 .000 
change * 
Group 
61812.979 1 61812.979 1.770 .190 
Table 11: Showing result on SGPT. 
Descriptive Statistics 
 Group Mean Std. Deviation N 
Pre test Group A 344.8174 256.02035 23 
Group  B 355.3087 358.01081 23 
Total 350.0630 307.79016 46 
Post test Group A 72.5043 21.58576 23 
Group B 71.2522 44.26792 23 
Total 71.8783 34.44193 46 
Tests of Within-Subjects Effects 





Change 1779895.785 1 1779895.785 43.152 0.000 
change * 
Group 
792.978 1 792.978 0.019 0.890 
Table 12: Showing result on Alkaline Phosphatase. 
Descriptive Statistics 
 Groups  Mean Std. Deviation N 
Pre test Group 
A 
319.3217 184.98424 23 
Group 
B 
336.0217 96.75050 23 
Total 327.6717 146.20864 46 
Post test Group 
A 
185.9043 77.99645 23 
Group 
B 
174.5391 57.11177 23 
Total 180.2217 67.83638 46 
Tests of Within-Subjects Effects 






Change 500054.557 1 500054.557 75.475 0.000 
change * 
Group 
4529.024 1 4529.024 0.684 0.413 
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Table 13: Showing the result on Overall Assessment. 
Overall 
Assessment 
Group A Group B Total 
Marked 
improvement 
13(56.5%) 14(60.9%) 27(58.7%) 
Moderate 
improvement 
9(39.1%) 8(34.8%) 17(37.0%) 
Mild 
improvement 
1(4.3%) 1(4.3%) 2(4.3%) 
Insignificant 
improvement 
0(0.00%) 0(0.00%) 0(0.00%) 
Total 23(100.0%) 23(100.0%) 46(100.0%) 
 
Symmetric Measures 
 Value Approx. Sig. 
Nominal by 
Nominal 
Cramer's V 0.046 0.953 
DISCUSSION 
The overall result in Group A, maximum number of 
subjects i.e., 13(56.5%) had marked improvement, 
9(39.1%) had moderate improvement, 1 subject 
(4.3%) had mild improvement. In  Group  B,  maximum  
number  of  subjects  i.e.,  14  (60.9%)  had  marked 
improvement,  8 (34.8%)  had moderate improvement  
and  1 subject (4.3%) had mild improvement. The 
result in between the two groups showed statistically 
non-significant result with p value 0.953. It showed  
that  both  the  Groups  have  similar  role  to  play  in  
the  management  of Kostashakhashrita Kamala vis-à-
vis Viral Hepatitis. 
The  formulations  selected  for  the  study  and  
probable  mode  of  action  were discussed as 
follows; 
All the drugs which are used in the formulations have 
some similar qualities with respect to their Rasa, 
Guna, Veerya and Vipaka. All have Katu and Tikta 
Rasa and Katu Vipaka in common, with respect to 
Guna Ruksha and Laghu are common in all the five  
ingredients  of  the  formulations.  Tikta Rasa  is  
mainly  having  Arochakaghna, Deepana,  Pachana,  
Jwaraghna  properties.  Laghu and  Ruksha  Guna  
does  the Upashoshana  of  Pitta.  Tikta Rasa  
facilitates  the  normal  function  of  Yakrit.  Katuki  is 
having  Pitta  Rechana  property  by  the  virtue  of  
Sara  Guna.  Which is essential  for Samprapti 
Vighatana of Kostashakhashrita Kamala. 
All the drugs which are used in the formulations have 
a property which seems to have  significant  role  in  
reducing  Pitta.  These  drugs  have  Pitta  Rechana, 
Raktashodhana,  Yakrit  Uttejaka,  Kandughna,  Daha 
Prashanmana, Jwaraghna, Rasayana and Balya 
properties. Amrita is having Kamalahara (Vyadhighna) 
property. Remaining four with respect to their 
Kamalahara properties have been substantiated by 
the recent researches  such  as  the  antiviral,  
hepatoprotecive,  anti-inflammatory,  antibacterial, 
heptic cell regenerator. 
Discussion on two different forms of formulations 
used in intervention 
The combined effect of Nimba, Amrita,  
Bhumyamalaki  and  Bhrnigaraja (NABB) Swarasa with 
Katuki Churna has been established. Even though 
these drugs are found  effective in the management 
of Viral  Hepatitis, the  form of drug  possess some 
practical problems i.e., to provide fresh Swarasa 
throughout the year is practical difficult  because  of  
non-availability  of  one  or  other  ingredient  
throughout  the  year. Proper preservation and 
storage is also difficult. Lastly the administration of 
these in the  form  of  Swarasa  may  not  suit  all  the  
subjects,  especially  those  who  are  in  the 
Amavastha of the disease.  
Among the Panchavidha Kashaya Kalpana, Kashaya is 
Laghu in nature so it is easily digestible and palatable. 
It is also noted that these raw drugs are available in 
almost all seasons, the method of preparation of 
Kashaya is very easy. Considering the above factors 
these effective drugs are presented in the form which 
can be stored and preserved for longer duration. 
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Hence comparative study of NABB Swarasa + Katuki 
Churna and NABBK Kashaya was selected. 
CONCLUSION 
Kamala is a Rakta Pradoshaja Vikara. In which hunger 
and appetite for food are diminished, simple meaning 
of Kamala is a disease where there is little or no 
desire for food according  to Harana  Chandra.  Bahu 
Pitta Kamala  is synonymous of Kostashkhastrita  
Kamala  and  Alpa  Pitta Kamala  is  synonymous  of  
Shakhashrita Kamala. Kostashakhashrita Kamala is 
Pitta Dosha predominant disease. The Dosha such as 
Ranjaka Pitta, Pachaka Pitta, Vyana Vata and Kledaka 
Kapha, Dushyas such as Rasa and Rakta, Srotas such 
as Pittavaha, Rasavaha and Raktavaha plays an 
important role in the pathogenesis of 
Kostashakhashrita Kamala. The study was conducted 
on 46 patients with 23 patients in each Group. In the 
study it was observed that both  the  Groups  have  
similar  role  to  play  in  the  management  of 
Kostashakhashrita Kamala vis-à-vis Viral Hepatitis. So 
it can be concluded that Swarasa is potent than 
Kashaya, but the form of drug possess some practical 
problems i.e. to  provide  fresh Swarasa  throughout  
the  year  is  practical  difficulty  because  of non-
availability of Bhringaraja and Bhumyamalaki 
throughout the year. Proper preservation and storage 
is also difficult. The administration of these in the 
form of Swarasa in the Amavastha of  the  disease  is  
difficult.  The  earlier  research  had  been established 
the efficacy  of  NABB Swarasa, the  present study  
was  taken to evaluate the  efficacy  of  NABBK  
Kashaya  based  on  the  convenience  of  
administration. Considering the above factors it can 
be concluded that it will be beneficial if these drugs 
are presented in the form which can be stored and 
preserved for longer duration. Hence NABBK Kashaya 
can be can be used as an alternative to NABB Swarasa 
with Katuki Churna  with  almost  the  same  efficacy.  
The shelf life of  Dravyas can  be extended in the  form 
of NABB Kashaya. 
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